Persons with dispensed medicines; origin
| Sex | Age | Origin | Medicine group (ATC) | Periods | Persons with dispensed medicines (number) | Persons with medicines, relative (%) |
|---|---|---|---|---|---|---|
| Total male and female | Total age | Total | A04 Antiemetics and antinauseants | 2021* | 109,225 | 0.61 |
| Total male and female | Total age | Total | A04A Antiemetics and antinauseants | 2021* | 109,225 | 0.61 |
| Total male and female | Total age | Total | A10 Drugs used in diabetes | 2021* | 848,950 | 4.74 |
| Total male and female | Total age | Total | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
| Total male and female | Total age | Total | A14 Anabolic agents for systemic use | 2021* | 400 | 0.00 |
| Total male and female | Total age | Total | C01D Vasodilators used in card. diseases | 2021* | 253,040 | 1.41 |
| Total male and female | Total age | Total | D01 Antifungals for dermatological use | 2021* | 762,635 | 4.26 |
| Total male and female | Total age | Total | D01A Antifungals for topical use | 2021* | 701,815 | 3.92 |
| Total male and female | Total age | Total | D01B Antifungals for systemic use | 2021* | 77,340 | 0.43 |
| Total male and female | Total age | Total | D05A Antipsoriatics for topical use | 2021* | 83,965 | 0.47 |
| Total male and female | Total age | Total | D05B Antipsoriatics for systemic use | 2021* | 3,795 | 0.02 |
| Total male and female | Total age | Total | D06 Antibiotics.. for dermatological use | 2021* | 684,235 | 3.82 |
| Total male and female | Total age | Total | D06A Antibiotics for topical use | 2021* | 561,225 | 3.13 |
| Total male and female | Total age | Total | D06B Chemotherapeutics for topical use | 2021* | 134,795 | 0.75 |
| Total male and female | Total age | Total | D10A Anti-acne preparations, topical use | 2021* | 163,490 | 0.91 |
| Total male and female | Total age | Total | D10B Anti-acne preparations,systemic use | 2021* | 32,070 | 0.18 |
| Total male and female | Total age | Total | G02B Contraceptives for topical use | 2021* | 18,730 | 0.10 |
| Total male and female | Total age | Total | G03A Hormonal contraceptives system. use | 2021* | 324,310 | 1.81 |
| Total male and female | Total age | Total | H02 Corticosteroids for systemic use | 2021* | 793,840 | 4.43 |
| Total male and female | Total age | Total | H02A Corticosteroids system.use, plain | 2021* | 785,225 | 4.38 |
| Total male and female | Total age | Total | H02B Corticosteroids system.use, combi. | 2021* | 10,715 | 0.06 |
| Total male and female | Total age | Total | J General antiinfectives for system.use | 2021* | 3,089,290 | 17.25 |
| Total male and female | Total age | Total | J01 Antibacterials for systemic use | 2021* | 2,834,430 | 15.83 |
| Total male and female | Total age | Total | J02 Antimycotics for systemic use | 2021* | 142,630 | 0.80 |
| Total male and female | Total age | Total | J02A Antimycotics for systemic use | 2021* | 142,630 | 0.80 |
| Total male and female | Total age | Total | J05 Antivirals for systemic use | 2021* | 115,510 | 0.65 |
| Total male and female | Total age | Total | N07B Drugs used in addictive disorders | 2021* | 57,425 | 0.32 |
| Total male and female | Total age | Total | R01B Nasal decongestants, systemic use | 2021* | 0 | 0.00 |
| Total male and female | Total age | Total | R03C Adrenergics for systemic use | 2021* | 65 | 0.00 |
| Total male and female | Total age | Total | R06 Antihistamines for systemic use | 2021* | 1,363,980 | 7.62 |
| Total male and female | Total age | Total | R06A Antihistamines for systemic use | 2021* | 1,363,980 | 7.62 |
| Total male and female | Total age | Origin: born in the Netherlands | A04 Antiemetics and antinauseants | 2021* | 97,965 | 0.64 |
| Total male and female | Total age | Origin: born in the Netherlands | A04A Antiemetics and antinauseants | 2021* | 97,965 | 0.64 |
| Total male and female | Total age | Origin: born in the Netherlands | A10 Drugs used in diabetes | 2021* | 668,425 | 4.39 |
| Total male and female | Total age | Origin: born in the Netherlands | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
| Total male and female | Total age | Origin: born in the Netherlands | A14 Anabolic agents for systemic use | 2021* | 365 | 0.00 |
| Total male and female | Total age | Origin: born in the Netherlands | C01D Vasodilators used in card. diseases | 2021* | 218,515 | 1.43 |
| Total male and female | Total age | Origin: born in the Netherlands | D01 Antifungals for dermatological use | 2021* | 646,845 | 4.25 |
| Total male and female | Total age | Origin: born in the Netherlands | D01A Antifungals for topical use | 2021* | 595,685 | 3.91 |
| Total male and female | Total age | Origin: born in the Netherlands | D01B Antifungals for systemic use | 2021* | 64,370 | 0.42 |
| Total male and female | Total age | Origin: born in the Netherlands | D05A Antipsoriatics for topical use | 2021* | 72,130 | 0.47 |
| Total male and female | Total age | Origin: born in the Netherlands | D05B Antipsoriatics for systemic use | 2021* | 3,285 | 0.02 |
| Total male and female | Total age | Origin: born in the Netherlands | D06 Antibiotics.. for dermatological use | 2021* | 615,600 | 4.04 |
| Total male and female | Total age | Origin: born in the Netherlands | D06A Antibiotics for topical use | 2021* | 509,090 | 3.34 |
| Total male and female | Total age | Origin: born in the Netherlands | D06B Chemotherapeutics for topical use | 2021* | 116,890 | 0.77 |
| Total male and female | Total age | Origin: born in the Netherlands | D10A Anti-acne preparations, topical use | 2021* | 134,575 | 0.88 |
| Total male and female | Total age | Origin: born in the Netherlands | D10B Anti-acne preparations,systemic use | 2021* | 27,335 | 0.18 |
| Total male and female | Total age | Origin: born in the Netherlands | G02B Contraceptives for topical use | 2021* | 17,985 | 0.12 |
| Total male and female | Total age | Origin: born in the Netherlands | G03A Hormonal contraceptives system. use | 2021* | 311,610 | 2.05 |
| Total male and female | Total age | Origin: born in the Netherlands | H02 Corticosteroids for systemic use | 2021* | 696,085 | 4.57 |
| Total male and female | Total age | Origin: born in the Netherlands | H02A Corticosteroids system.use, plain | 2021* | 688,810 | 4.52 |
| Total male and female | Total age | Origin: born in the Netherlands | H02B Corticosteroids system.use, combi. | 2021* | 9,140 | 0.06 |
| Total male and female | Total age | Origin: born in the Netherlands | J General antiinfectives for system.use | 2021* | 2,678,635 | 17.58 |
| Total male and female | Total age | Origin: born in the Netherlands | J01 Antibacterials for systemic use | 2021* | 2,464,525 | 16.18 |
| Total male and female | Total age | Origin: born in the Netherlands | J02 Antimycotics for systemic use | 2021* | 121,220 | 0.80 |
| Total male and female | Total age | Origin: born in the Netherlands | J02A Antimycotics for systemic use | 2021* | 121,220 | 0.80 |
| Total male and female | Total age | Origin: born in the Netherlands | J05 Antivirals for systemic use | 2021* | 90,145 | 0.59 |
| Total male and female | Total age | Origin: born in the Netherlands | N07B Drugs used in addictive disorders | 2021* | 47,895 | 0.31 |
| Total male and female | Total age | Origin: born in the Netherlands | R01B Nasal decongestants, systemic use | 2021* | 0 | 0.00 |
| Total male and female | Total age | Origin: born in the Netherlands | R03C Adrenergics for systemic use | 2021* | 55 | 0.00 |
| Total male and female | Total age | Origin: born in the Netherlands | R06 Antihistamines for systemic use | 2021* | 1,164,980 | 7.65 |
| Total male and female | Total age | Origin: born in the Netherlands | R06A Antihistamines for systemic use | 2021* | 1,164,980 | 7.65 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A04 Antiemetics and antinauseants | 2021* | 83,580 | 0.63 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A04A Antiemetics and antinauseants | 2021* | 83,580 | 0.63 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A10 Drugs used in diabetes | 2021* | 613,900 | 4.66 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
| Total male and female | Total age | Origin: born in NL, parents in NL | A14 Anabolic agents for systemic use | 2021* | 330 | 0.00 |
| Total male and female | Total age | Origin: born in NL, parents in NL | C01D Vasodilators used in card. diseases | 2021* | 203,330 | 1.54 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D01 Antifungals for dermatological use | 2021* | 553,135 | 4.20 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D01A Antifungals for topical use | 2021* | 509,230 | 3.86 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D01B Antifungals for systemic use | 2021* | 54,895 | 0.42 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D05A Antipsoriatics for topical use | 2021* | 63,760 | 0.48 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D05B Antipsoriatics for systemic use | 2021* | 3,045 | 0.02 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D06 Antibiotics.. for dermatological use | 2021* | 530,465 | 4.02 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D06A Antibiotics for topical use | 2021* | 437,160 | 3.32 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D06B Chemotherapeutics for topical use | 2021* | 102,400 | 0.78 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D10A Anti-acne preparations, topical use | 2021* | 101,390 | 0.77 |
| Total male and female | Total age | Origin: born in NL, parents in NL | D10B Anti-acne preparations,systemic use | 2021* | 19,880 | 0.15 |
| Total male and female | Total age | Origin: born in NL, parents in NL | G02B Contraceptives for topical use | 2021* | 16,030 | 0.12 |
| Total male and female | Total age | Origin: born in NL, parents in NL | G03A Hormonal contraceptives system. use | 2021* | 273,470 | 2.07 |
| Total male and female | Total age | Origin: born in NL, parents in NL | H02 Corticosteroids for systemic use | 2021* | 636,435 | 4.83 |
| Total male and female | Total age | Origin: born in NL, parents in NL | H02A Corticosteroids system.use, plain | 2021* | 629,675 | 4.78 |
| Total male and female | Total age | Origin: born in NL, parents in NL | H02B Corticosteroids system.use, combi. | 2021* | 8,495 | 0.06 |
| Total male and female | Total age | Origin: born in NL, parents in NL | J General antiinfectives for system.use | 2021* | 2,348,450 | 17.82 |
| Total male and female | Total age | Origin: born in NL, parents in NL | J01 Antibacterials for systemic use | 2021* | 2,159,585 | 16.38 |
| Total male and female | Total age | Origin: born in NL, parents in NL | J02 Antimycotics for systemic use | 2021* | 104,040 | 0.79 |
| Total male and female | Total age | Origin: born in NL, parents in NL | J02A Antimycotics for systemic use | 2021* | 104,040 | 0.79 |
| Total male and female | Total age | Origin: born in NL, parents in NL | J05 Antivirals for systemic use | 2021* | 78,985 | 0.60 |
| Total male and female | Total age | Origin: born in NL, parents in NL | N07B Drugs used in addictive disorders | 2021* | 42,630 | 0.32 |
| Total male and female | Total age | Origin: born in NL, parents in NL | R01B Nasal decongestants, systemic use | 2021* | 0 | 0.00 |
| Total male and female | Total age | Origin: born in NL, parents in NL | R03C Adrenergics for systemic use | 2021* | 45 | 0.00 |
| Total male and female | Total age | Origin: born in NL, parents in NL | R06 Antihistamines for systemic use | 2021* | 973,975 | 7.39 |
| Total male and female | Total age | Origin: born in NL, parents in NL | R06A Antihistamines for systemic use | 2021* | 973,975 | 7.39 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | A04 Antiemetics and antinauseants | 2021* | 14,385 | 0.70 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | A04A Antiemetics and antinauseants | 2021* | 14,385 | 0.70 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | A10 Drugs used in diabetes | 2021* | 54,520 | 2.66 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | A10X Other drugs used in diabetes | 2021* | 0 | 0.00 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | A14 Anabolic agents for systemic use | 2021* | 35 | 0.00 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | C01D Vasodilators used in card. diseases | 2021* | 15,185 | 0.74 |
| Total male and female | Total age | Origin: born in NL, parent(s) outside NL | D01 Antifungals for dermatological use | 2021* | 93,710 | 4.57 |
| Source: CBS. | ||||||
Dataset is not available.
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, origin, age and sex.
Data available from 2020.
Status of the figures:
All figures are provisional.
Changes as of 22 February, 2023:
'Origin: total' and 'Origin country: total' are replaced with one total.
When will new figures be published?
New figures will be published in the last quarter of 2023.
Description topics
- Persons with dispensed medicines
- Number of persons registered in the Basic Registration of Persons (BRP) in the year concerned to whom medicines are dispensed in that year that are reimbursed under the statutory basic medical insurance.
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.